Get Harrow alerts:Harrow, Inc. (NASDAQ:HROW – Free Report) – Research analysts at B. Riley lowered their Q3 2025 EPS estimates for shares of Harrow in a report released on Tuesday, September 30th. B. Riley also issued estimates for Harrow’s FY2025 earnings at $0.82 EPS, FY2026 earnings at $2.86 EPS and FY2027 earnings at $4.34 EPS. Harrow (NASDAQ:HROW – Get Free Report) last released its quarterly earnings data on Monday, August 11th. Get Our Latest Stock Report on HarrowHarrow Stock Down 4.8%Harrow stock opened at $45.43 on Friday. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business.